Divis Laboratories Ltd | DIVI - Interest Expense On Debt


Divis Laboratories Ltd reported INR60M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Aurobindo Pharma INR 982.1M 54.4M Mar/2026
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Mar/2026
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Lupin INR 1.15B 73.9M Dec/2025
Moderna USD 11.49B 36B Mar/2026
Organon & Co USD 128M 3M Sep/2025
Revvity USD 24.72M 1.2M Mar/2026
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 120.1M 500K Mar/2026
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025